| | Variables | Difficult hemostasis | P value | | No (n = 546) | Yes (n = 74) |
| | Gender, n (%) | | | 0.038 | | Female | 124 (22.71) | 9 (12.16) | | | Man | 422 (77.29) | 65 (87.84) | | | Age (years) | 65 (59-70) | 65 (59-70) | 0.757 | | Smoking, n (%) | | | 0.003 | | No | 214 (39.19) | 16 (21.62) | | | Yes | 332 (60.81) | 58 (78.38) | | | SBP (mmHg) | 131 (119-145) | 128 (111-143) | 0.184 | | DBP (mmHg) | 78 (70-86) | 70 (70-88) | 0.326 | | Weight (kg) | 60 (53-66) | 60 (53-70) | 0.353 | | COPD, n (%) | | | 0.738 | | No | 511 (93.59) | 70 (94.59) | | | Yes | 35 (6.41) | 4 (5.41) | | | Diabetes, n (%) | | | 0.410 | | No | 516 (94.51) | 72 (97.30) | | | Yes | 30 (5.49) | 2 (2.70) | | | CHD, n (%) | | | 0.722 | | No | 529 (96.89) | 71 (95.95) | | | Yes | 17 (3.11) | 3 (4.05) | | | Pulmonary infection, n (%) | | | <0.001 | | No | 340 (62.27) | 28 (37.84) | | | Yes | 206 (37.73) | 46 (62.16) | | | Cancer stage, n (%) | | | 0.824 | | Early | 295 (54.03) | 41 (55.41) | | | Advanced | 251 (45.97) | 33 (44.59) | | | Histological types, n (%) | | | <0.001 | | Adenocarcinoma | 161 (29.49) | 5 (6.76) | | | Squamous cell carcinoma | 254 (46.52) | 59 (79.73) | | | SCLC | 101 (18.50) | 8 (10.81) | | | Others | 30 (5.49) | 2 (2.70) | | | Lesion location, n (%) | | | <0.001 | | Left main bronchus | 29 (5.31) | 8 (10.81) | | | Left upper lobar bronchi | 129 (23.63) | 13 (17.57) | | | Left lower lobar bronchi | 98 (17.95) | 10 (13.51) | | | Right main bronchus | 16 (2.93) | 8 (10.81) | | | Right upper lobar bronchi | 137 (25.09) | 14 (18.92) | | | Right middle bronchus | 21 (3.85) | 8 (10.81) | | | Right middle lobar bronchi | 27 (4.95) | 2 (2.70) | | | Right lower lobar bronchi | 84 (15.38) | 7 (9.46) | | | The trachea | 5 (0.92) | 4 (5.41) | | | Hospitalization, (days) | 11 (7-15) | 10 (7-14) | 0.360 | | WBC (×109/L) | 6.80 (5.45-8.50) | 6.89 (5.43-8.88) | 0.914 | | Neutrophil (%) | 69.2 (61.8-75.6) | 72.6 (65.8-80.9) | 0.004 | | Neutrophils (×109/L) | 4.54 (3.50-6.35) | 5.10 (3.82-6.70) | 0.787 | | Hemoglobin (g/dl) | 128 (116-140) | 126 (112-137) | 0.256 | | Platelets (×109/L) | 222 (173-280) | 245 (171-317) | 0.086 | | CRP (mg/L) | 5.9 (1.1-31.8) | 18.66 (3.8-44.5) | <0.001 | | PT (s) | 13.0 (12.1-13.6) | 13.3 (12.2-13.9) | 0.663 | | APTT (s) | 34.8 (31.5-38.2) | 36.2 (33.0-41.2) | 0.034 | | ALT (IU/L) | 17.0 (12.0-26.0) | 15.1 (12.0-21.4) | 0.184 | | AST (IU/L) | 23.0 (19.0-29.0) | 23.0 (18.0-27.1) | 0.233 | | Homocysteine (μmol/L) | 13.3 (10.7-16.6) | 12.7 (10.1-15.7) | 0.627 | | Triglyceride (mmol/L) | 1.08 (0.79-1.46) | 0.96 (0.71-1.15) | 0.006 | | TC (mmol/L) | 4.10 (3.46-4.77) | 4.06 (3.53-4.77) | 0.720 | | HDL-C (mmol/L) | 1.14 (0.94-1.37) | 1.07 (0.92-1.22) | 0.072 | | LDL-C (mmol/L) | 2.75 (2.26-3.30) | 2.86 (2.42-3.40) | 0.074 | | Apolipoprotein-B (g/L) | 0.96 (0.77-1.18) | 0.95 (0.80-1.15) | 0.425 | | Apolipoprotein-E (mg/dL) | 3.60 (2.90-4.80) | 2.95 (2.40-3.98) | 0.006 |
|
|
SBP, systolic blood pressure; DBP, diastolic blood pressure; COPD, chronic obstructive pulmonary disease; CHD, coronary heart disease; SCLC, small-cell lung carcinoma; WBC, white blood cell; CRP, C-reactive protein; PT, prothrombin time; APTT, activated partial thromboplastin time; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.
|
